Aramex announces strategic logistics partnership with NewBridge Pharmaceuticals

Press release
Published August 23rd, 2016 - 06:05 GMT
Hussein Hachem, Chief Executive Officer of Aramex
Hussein Hachem, Chief Executive Officer of Aramex

Aramex, a leading global provider of comprehensive logistics and transportation solutions, has recently announced its partnership with NewBridge Pharmaceuticals. As part of this collaboration, Aramex is now providing a range of logistics services for NewBridge in the Middle East, Africa, Canada and the UK.

Based in Dubai, UAE, NewBridge pharmaceuticals is a regional specialty company providing a one-stop-solution to pharmaceuticals, biological, genomics and other innovative healthcare companies. The focus is on in-licensing and commercializing FDA and EMA/European approved innovative therapeutics and diagnostics that address unmet medical needs of diseases with high prevalence within the emerging markets of the Middle East & Africa region.

Through the partnership, Aramex is managing the logistics of  patient samples across any clinics and hospitals from the Middle East to the U.S. for advanced clinical testing. Aramex is also providing temperature controlled storage and transportation of medication for NewBridge from various distribution hubs in the UK and Canada to healthcare facilities within the Middle East and Africa.

Furthermore, Aramex is providing NewBridge with customs clearance, secondary packaging, labeling, vaulting and guarded transport services as part of the partnership.

Commenting on the agreement, Hussein Hachem, CEO of Aramex, said: “We are excited to have partnered with NewBridge Pharmaceuticals. This collaboration is a testimony to our healthcare solutions which not only enable our healthcare customers to grow globally, but also provide access to quality healthcare service to citizens across our region. By working closely with NewBridge we are able to further penetrate the healthcare market, take advantage of the increased demand for logistics services in the pharmaceutical industry and better support people who require medicine and other pharmaceutical needs to be delivered to them effectively and efficiently. Not only are we proud to be a part of improving peoples’ health in the region, but this partnership with NewBridge also attests to the quality and reliability of the logistics services that we provide.”

Further commenting on the agreement, Joe Henein , CEO of NewBridge Pharmaceuticals, said: “This partnership with Aramex gives us significant opportunities to expand our business proposition and take advantage of the increasing demand for our solutions across the Middle East and Africa. We are dedicated to addressing the medical needs of our customers and this partnership allows us to reach more businesses and patients who rely on our full range of pharmaceutical services. Aramex also has a well-recognised brand, stable business and a leadership position in the region, making them an ideal partner for us to extend our reach in the market. The credibility and quality of their services makes them the best-suited business partner for the services we provide. We remain committed to servicing the Middle East and Africa and this partnership will allow us to serve more businesses and consumers who need critical medical attention in the region.”

As the global healthcare market continues to develop, regulation and compliance for the transportation and storage of medicine is becoming more stringent. This collaboration between Aramex and NewBridge is consequently filling a gap in the market by ensuring medicines, human specimens and other pharmaceutical goods are being securely, safely and efficiently transported throughout the region in line with local regulations.

In addition to having facility hubs based in the UK and Canada, Aramex plans to set up a third facility hub in the U.S. soon, and will continue to handle the storage, transport and delivery of NewBridge’s medicine and other pharmaceutical goods.

Background Information

Aramex

Aramex has rapidly grown into a global brand, recognized for its customized services and innovative products. Listed on the Dubai Financial Market (DFM) and based in the UAE, Aramex is centrally located at the crossroads between East and West, which allows us to provide customized logistics solutions anywhere in the world effectively and reach more businesses and consumers regionally and globally.

توقيف 41 شخصا في مظاهرات الجزائر

Published February 23rd, 2019 - 09:07 GMT
توقيف 41 شخصا في مظاهرات الجزائر
توقيف 41 شخصا في مظاهرات الجزائر

أعلنت المديرية العامة للأمن الوطني (الشرطة) الجزائرية، مساء الجمعة، توقيف 41 شخصا في مظاهرات شهدتها عدة مدن ضد ترشح الرئيس عبد العزيز بوتفليقة لولاية خامسة في انتخابات 18 أبريل/ نيسان القادم.

وأكدت إدارة الشرطة في بيان اطلعت عليه وكالة الاناضول أن عمليات التوقيف كانت بسبب “الإخلال بالنظام العام والاعتداء على القوة العامة وتحطيم الممتلكات” دون تقديم تفاصيل أكثر حول أماكن توقيف هؤلاء المتظاهرين.

والجمعة، استجاب آلاف المواطنين بعدة محافظات جزائرية، إلى دعوات للتظاهر تم تداولها عبر شبكات التواصل، ضد ترشح بوتفليقة (81 عاما) لولاية خامسة في انتخابات الرئاسة المقررة في 18 أبريل/ نيسان القادم.

واتسمت هذه المظاهرات بالسلمية في أغلب مناطق البلاد باستثناء حدوث مواجهات بين قوات مكافحة الشغب ومتظاهرين بوسط العاصمة خلال محاولتهم السير نحو القصر الرئاسي .

ووفق شهود عيان لجأت قوات الأمن إلى الغاز المسيل للدموع وتوقيف عدة أشخاص بعد تحذيرات للمتظاهرين وتعرضها للرشق بمقذوفات وحجارة قبل أن يتراجع المحتجون ويغادروا المكان.

وصبيحة اليوم نشر ناشطون معلومات عبر شبكات التواصل الاجتماعي حول توقيف عدد من زملائهم قبل بداية المظاهرات بالعاصمة.

وعلقت الرابطة الجزائرية للدفاع عن حقوق الإنسان (مستقلة) على بيان الشرطة بالمطالبة ب”الإفراج الفوري عن الموقوفين وان يتم احترام حق التظاهر سلميا” كما نشرت على صفحتها بموقع “فيسبوك”.

الأناضول


© 2000 - 2019 Al Bawaba (www.albawaba.com)

You may also like

PR Contact

Contact Name
Bush Taylyn
Contact email

Previous PR’s

PR Rates

Buy credits to publish your articles on Al Bawaba Biz here

You May Also Like

Subscribe

Sign up to our newsletter for exclusive updates and enhanced content